ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID BENNION MD

Internal Medicine

13,710

$858K

434
380 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

MICHAEL KILLPACK MD

Internal Medicine

12,958

$871K

436
305 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $62

ROBERT RIGNELL MD

Internal Medicine

11,682

$644K

609
575 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

ROBERT CORNIEA MD

Internal Medicine

9,587

$688K

473
431 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $62

ROBERT MOHR MD

Internal Medicine

7,888

$458K

346
270 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

SEAN CURZON DO

Internal Medicine

10,975

$838K

429
360 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $62

JON HUGHES MD PC

Internal Medicine

14,615

$575K

428
360 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $62

WILLIAM BARNEY MD

Internal Medicine

8,356

$434K

415
378 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

BRUCE BURTENSHAW MD

Internal Medicine

12,803

$611K

482
423 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $62

CHAD KIMBALL M.D.

Internal Medicine

4,460

$244K

398
341 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

PETER DUROS MD

Internal Medicine

15,300

$837K

647
558 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

KAVITA WILLESEN MD

Internal Medicine

7,940

$521K

553
476 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $62

JOSEPH WOOLLEY M.D.

Internal Medicine

8,015

$549K

528
479 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $62

E GENEBACH MD

Internal Medicine

9,293

$576K

473
459 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $62

GARRY MILLER D.O.

Internal Medicine

7,967

$464K

449
390 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

YUN LING MD

Internal Medicine

8,022

$409K

518
428 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

NEDDA HENDLER MD

Internal Medicine

7,315

$460K

394
352 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

PHILLIP SMITH MD

Internal Medicine

13,705

$1.12M

589
470 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $62

J PARKINSON DO

Internal Medicine

8,804

$680K

615
545 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $62

CLAUDE WARNER MD

Internal Medicine

11,988

$742K

482
431 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $62

MICHAEL STONES MD

Internal Medicine

17,274

$1.12M

809
763 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

JOHN MARKESON M.D.

Internal Medicine

17,596

$818K

763
667 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $62

KEVIN TSCHETTER MD

Internal Medicine

11,751

$676K

613
532 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

RICHARD OLSEN MD

Internal Medicine

9,447

$572K

444
420 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $62

JEFFREY CALL M.D.

Internal Medicine

14,618

$1.09M

737
668 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank